Ubs Group Ag Electro Core, Inc. Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.46 - $0.68 $19,652 - $29,051
42,723 Added 145.26%
72,134 $29,000
Q2 2022

Aug 10, 2022
SELL
$0.27 - $0.61 $8,232 - $18,598
-30,489 Reduced 50.9%
29,411 $15,000
Q1 2022

May 16, 2022
SELL
$0.5 - $0.88 $334 - $588
-669 Reduced 1.1%
59,900 $35,000
Q4 2021

Feb 14, 2022
BUY
$0.58 - $1.09 $20,283 - $38,118
34,971 Added 136.62%
60,569 $36,000
Q3 2021

Nov 15, 2021
BUY
$0.93 - $1.18 $16,425 - $20,841
17,662 Added 222.56%
25,598 $29,000
Q2 2021

Aug 13, 2021
SELL
$1.19 - $2.06 $33,466 - $57,933
-28,123 Reduced 77.99%
7,936 $9,000
Q1 2021

May 12, 2021
BUY
$1.62 - $3.05 $38,228 - $71,973
23,598 Added 189.37%
36,059 $74,000
Q4 2020

Feb 11, 2021
BUY
$1.44 - $1.98 $6,516 - $8,959
4,525 Added 57.02%
12,461 $19,000
Q3 2020

Nov 12, 2020
SELL
$0.8 - $2.33 $3,947 - $11,496
-4,934 Reduced 38.34%
7,936 $14,000
Q2 2020

Jul 31, 2020
BUY
$0.75 - $1.29 $207 - $357
277 Added 2.2%
12,870 $11,000
Q1 2020

May 01, 2020
SELL
$0.33 - $1.62 $2,172 - $10,662
-6,582 Reduced 34.33%
12,593 $12,000
Q4 2019

Feb 14, 2020
BUY
$1.23 - $2.67 $6,607 - $14,343
5,372 Added 38.92%
19,175 $31,000
Q3 2019

Nov 14, 2019
BUY
$1.25 - $5.0 $10,328 - $41,315
8,263 Added 149.15%
13,803 $31,000
Q2 2019

Aug 14, 2019
BUY
$1.65 - $6.72 $4,191 - $17,068
2,540 Added 84.67%
5,540 $11,000
Q1 2019

May 14, 2019
BUY
$4.84 - $9.07 $3,688 - $6,911
762 Added 34.05%
3,000 $21,000
Q4 2018

Feb 14, 2019
BUY
$4.21 - $14.28 $3,464 - $11,752
823 Added 58.16%
2,238 $14,000
Q3 2018

Nov 14, 2018
BUY
$13.02 - $17.54 $18,423 - $24,819
1,415 New
1,415 $20,000

Others Institutions Holding ECOR

# of Institutions
3
Shares Held
143K
Call Options Held
0
Put Options Held
0
View Full List

About electroCore, Inc.

ECOR Quotes by TradingView
  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $445M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email